Sign in

2024-517237-40-00RecruitingPhase 1/2

AZALOX Study: Safety and Efficacy of PXS-5505 with 5-Azacitidine in MDS and CMML Patients

Source: EU CTIS (euclinicaltrials.eu) · Last updated 16 Oct 2026

Status (registry)
Recruiting
Phase (registry)
Phase 1/2
Study type
Interventional
Enrollment
42 (estimated)
First submitted
30 Jan 2025
Start date
3 Jul 2025
Lead sponsor
Heidelberg University
EU CT number
2024-517237-40-00

What you commit to

  • Study type: Interventional · Phase 1/2
  • Planned participants: 42
  • 10 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.

Sites (10)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Universitaetsklinikum Bonn AöR
Coordinator of this site? Confirm its status
BonnGermanyRecruiting
Universitaetsklinikum Carl Gustav Carus Dresden an der Technischen Universitaet Dresden AöR
Coordinator of this site? Confirm its status
DresdenGermanyRecruiting
Universitaetsklinikum Duesseldorf AöR
Coordinator of this site? Confirm its status
DuesseldorfGermanyRecruiting
Universitaetsmedizin Goettingen
Coordinator of this site? Confirm its status
GoettingenGermanyRecruiting
Medizinische Hochschule Hannover
Coordinator of this site? Confirm its status
HanoverGermanyRecruiting
Universitaetsklinikum Schleswig-Holstein AöR
Coordinator of this site? Confirm its status
LuebeckGermanyRecruiting
Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR
Coordinator of this site? Confirm its status
MainzGermanyRecruiting
Heidelberg University
Coordinator of this site? Confirm its status
MannheimGermanyRecruiting
Klinikum der Technischen Universitaet Muenchen (TUM Klinikum)
Coordinator of this site? Confirm its status
MunichGermanyRecruiting
Klinikum Oldenburg Aor
Coordinator of this site? Confirm its status
OldenburgGermanyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.